We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$21.2B
AUM Growth
+$1.07B
(+5.3%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
1.06%
Top 10 Holdings %
Top 10 Hldgs %
9.44%
Holding
1,639
New
311
Increased
467
Reduced
550
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$211M |
| 2 |
AbbVie
ABBV
|
+$176M |
| 3 |
Apple
AAPL
|
+$170M |
| 4 |
Nike
NKE
|
+$161M |
| 5 |
Coca-Cola
KO
|
+$141M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$221M |
| 2 |
Medtronic
MDT
|
+$163M |
| 3 |
UnitedHealth
UNH
|
+$148M |
| 4 |
Johnson & Johnson
JNJ
|
+$133M |
| 5 |
Pfizer
PFE
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.66% |
| 2 | Consumer Discretionary | 14.98% |
| 3 | Healthcare | 13.91% |
| 4 | Financials | 10.93% |
| 5 | Industrials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
OFG Bancorp
OFG
$2.26B
| $257K | ﹤0.01% |
+9,856
| New | +$247K |
|
1302
Banc of California
BANC
$3.11B
| $256K | ﹤0.01% |
22,067
+10,494
| +91% | +$121K |
|
|
ACCD
1303
DELISTED
Accolade Inc
ACCD
| $251K | ﹤0.01% |
18,643
-173,886
| -90% | -$2.26M |
|
1304
Clear Secure
YOU
$4.7B
| $248K | ﹤0.01% |
+10,709
| New | +$265K |
|
1305
Toronto Dominion Bank
TD
$203B
| $242K | ﹤0.01% |
3,898
-195,343
| -98% | -$11.8M |
|
1306
TTEC Holdings
TTEC
$77.4M
| $240K | ﹤0.01% |
+7,090
| New | +$243K |
|
|
VSTO
1307
DELISTED
Vista Outdoor Inc.
VSTO
| $230K | ﹤0.01% |
+8,303
| New | +$225K |
|
1308
KT
KT
$9.03B
| $229K | ﹤0.01% |
20,286
-109,152
| -84% | -$1.27M |
|
|
KYNB
1309
Kyntra Bio
KYNB
$28.5M
| $228K | ﹤0.01% |
3,375
-9,579
| -74% | -$3.96M |
|
1310
Nabors Industries
NBR
$1.35B
| $224K | ﹤0.01% |
2,406
+710
| +42% | +$72.2K |
|
1311
Federated Hermes
FHI
$4.74B
| $220K | ﹤0.01% |
6,143
+934
| +18% | +$36.1K |
|
1312
Ionis Pharmaceuticals
IONS
$9.28B
| $219K | ﹤0.01% |
+5,348
| New | +$206K |
|
1313
Otis Worldwide
OTIS
$27.8B
| $216K | ﹤0.01% |
2,430
-87,998
| -97% | -$7.41M |
|
1314
Gogo Inc
GOGO
$377M
| $216K | ﹤0.01% |
+12,696
| New | +$188K |
|
1315
Central Garden & Pet Co Class A
CENTA
$2.41B
| $216K | ﹤0.01% |
+7,389
| New | +$213K |
|
|
MRUS
1316
DELISTED
Merus
MRUS
| $215K | ﹤0.01% |
+8,171
| New | +$179K |
|
1317
Teva Pharmaceuticals
TEVA
$42.6B
| $207K | ﹤0.01% |
+27,489
| New | +$223K |
|
1318
Kforce
KFRC
$1.08B
| $205K | ﹤0.01% |
3,265
-28,423
| -90% | -$1.71M |
|
1319
Fidelity National Financial
FNF
$13.1B
| $202K | ﹤0.01% |
+5,607
| New | +$196K |
|
1320
Haleon
HLN
$43.2B
| $189K | ﹤0.01% |
+22,546
| New | +$192K |
|
1321
DigitalBridge
DBRG
$2.94B
| $179K | ﹤0.01% |
+12,140
| New | +$149K |
|
1322
Hercules Capital
HTGC
$3.17B
| $158K | ﹤0.01% |
+10,705
| New | +$147K |
|
1323
PureCycle Technologies
PCT
$1.41B
| $151K | ﹤0.01% |
+14,107
| New | +$102K |
|
1324
Alight
ALIT
$394M
| $128K | ﹤0.01% |
693
-10,795
| -94% | -$1.92M |
|
1325
Rithm Capital
RITM
$5.79B
| $115K | ﹤0.01% |
+12,308
| New | +$103K |
|
Similar funds
VAI
JG
OAG
Voloridge Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, Voloridge Investment Management held 1,639 positions worth $21.2B, up 5.3% from $20.1B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Voloridge Investment Management's Q2 2023 filing shows 311 new, 467 increased, 550 reduced and 311 closed positions. Its largest new stake was Berkshire Hathaway Class B: 646,010 shares worth $220M. The largest sale was Accenture, an estimated $221M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Voloridge Investment Management's largest Q2 2023 buy was Berkshire Hathaway Class B: 646,010 shares worth $220M.
- Voloridge Investment Management added most to Coca-Cola in Q2 2023, an estimated $141M increase.
- Voloridge Investment Management's biggest Q2 2023 reduction was Medtronic, cutting an estimated $163M.
- Voloridge Investment Management fully exited Accenture in Q2 2023, selling an estimated $221M.
- Voloridge Investment Management's ten largest holdings make up 9.4% of its $21.2B portfolio in Q2 2023.
- Voloridge Investment Management opened 311 new positions and closed 311 in Q2 2023.
- Voloridge Investment Management's portfolio value rose 5.3% quarter-over-quarter to $21.2B.
Based on Voloridge Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.